Vaxigrip susp inj 2025/2026, , Vaxigrip susp inj 2025/2026 ser pré 0.5 ml

7680700510035 Pharmacode 1153629 CH-70051 J07BB02

No images available

Details

GTIN
7680700510035
Pharmacode
1153629
Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
18/07/2026
Professional SmPC
Français
18/07/2026
Professional SmPC
Italien
18/07/2026

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H1N1)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae A (H3N2)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
15.0 UG Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
kalii chloridum
- Substance HNIDK
dinatrii phosphas dihydricus
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.72 MG Substance HBESI
kalium
0.08 MG Substance HBESI
formaldehydum
- Substance RESI
octoxinolum-9
- Substance RESI
ovalbuminum
- Substance RESI
neomycinum
- Substance RESI

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
70051
Drug name
Vaxigrip, suspension injectable
Galenic form
SUPAS
ATC Code
J07BB02
Authorization status
Z
Dispensation category
B
First authorization
06/05/2025
Authorization expiration date
05/05/2030
IT number
08.08.
Domain
Human medicine

Packaging details

Description (FR)
VAXIGRIP susp inj 15 µg 1 pce
Description (DE)
VAXIGRIP Inj Susp 15 µg 1 Stk
Market launch
01/11/2025
Market withdrawal
07/09/2026
Narcotic (BTM)
No

Other packaging sizes

VAXIGRIP susp inj 2026/2027 ser pré 0.5 ml
1 FESP
View
VAXIGRIP susp inj 2026/2027 10 ser pré 0.5 ml
10 FESP
View
Buy us a coffee Explore the data